Works matching AU Zhu, Xianbing

Results: 14
    1

    SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca<sup>2+</sup> flux to mitochondria.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25260-9
    By:
    • Xue, Yibo;
    • Morris, Jordan L.;
    • Yang, Kangning;
    • Fu, Zheng;
    • Zhu, Xianbing;
    • Johnson, Fraser;
    • Meehan, Brian;
    • Witkowski, Leora;
    • Yasmeen, Amber;
    • Golenar, Tunde;
    • Coatham, Mackenzie;
    • Morin, Geneviève;
    • Monast, Anie;
    • Pilon, Virginie;
    • Fiset, Pierre Olivier;
    • Jung, Sungmi;
    • Gonzalez, Anne V.;
    • Camilleri-Broet, Sophie;
    • Fu, Lili;
    • Postovit, Lynne-Marie
    Publication type:
    Article
    2

    Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38594-3
    By:
    • Zhu, Xianbing;
    • Fu, Zheng;
    • Chen, Shary Y.;
    • Ong, Dionzie;
    • Aceto, Giulio;
    • Ho, Rebecca;
    • Steinberger, Jutta;
    • Monast, Anie;
    • Pilon, Virginie;
    • Li, Eunice;
    • Ta, Monica;
    • Ching, Kyle;
    • Adams, Bianca N.;
    • Negri, Gian L.;
    • Choiniere, Luc;
    • Fu, Lili;
    • Pavlakis, Kitty;
    • Pirrotte, Patrick;
    • Avizonis, Daina Z.;
    • Trent, Jeffrey
    Publication type:
    Article
    3

    Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca<sup>2+</sup> flux to mitochondria.

    Published in:
    2023
    By:
    • Xue, Yibo;
    • Morris, Jordan L.;
    • Yang, Kangning;
    • Fu, Zheng;
    • Zhu, Xianbing;
    • Johnson, Fraser;
    • Meehan, Brian;
    • Witkowski, Leora;
    • Yasmeen, Amber;
    • Golenar, Tunde;
    • Coatham, Mackenzie;
    • Morin, Geneviève;
    • Monast, Anie;
    • Pilon, Virginie;
    • Fiset, Pierre Olivier;
    • Jung, Sungmi;
    • Gonzalez, Anne V.;
    • Camilleri-Broet, Sophie;
    • Fu, Lili;
    • Postovit, Lynne-Marie
    Publication type:
    Correction Notice
    4
    5
    6
    7
    8
    9
    10
    11
    12

    SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08380-1
    By:
    • Xue, Yibo;
    • Meehan, Brian;
    • Fu, Zheng;
    • Wang, Xue Qing D.;
    • Fiset, Pierre Olivier;
    • Rieker, Ralf;
    • Levins, Cameron;
    • Kong, Tim;
    • Zhu, Xianbing;
    • Morin, Geneviève;
    • Skerritt, Lashanda;
    • Herpel, Esther;
    • Venneti, Sriram;
    • Martinez, Daniel;
    • Judkins, Alexander R.;
    • Jung, Sungmi;
    • Camilleri-Broet, Sophie;
    • Gonzalez, Anne V.;
    • Guiot, Marie-Christine;
    • Lockwood, William W.
    Publication type:
    Article
    13
    14

    SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.

    Published in:
    Journal of Pathology, 2020, v. 252, n. 1, p. 77, doi. 10.1002/path.5493
    By:
    • Xue, Yibo;
    • Zhu, Xianbing;
    • Meehan, Brian;
    • Venneti, Sriram;
    • Martinez, Daniel;
    • Morin, Geneviève;
    • Maïga, Rayelle I;
    • Chen, Hongbo;
    • Papadakis, Andreas I;
    • Johnson, Radia M;
    • O'Sullivan, Maureen J;
    • Erdreich‐Epstein, Anat;
    • Gotlieb, Walter H;
    • Park, Morag;
    • Judkins, Alexander R;
    • Pelletier, Jerry;
    • Foulkes, William D;
    • Rak, Janusz;
    • Huang, Sidong
    Publication type:
    Article